Your osteoarthritis journey
Stock photo – posed by models.
Osteoarthritis (OA) is a chronic degenerative joint disease that occurs when the cartilage that cushions the joint gradually deteriorates.
OA is the most common form of arthritis. It affects more Canadians than all other forms of arthritis combined.
Understand your joint pain
Explore treatment options for OA-related pain
Get your injection
Considerations for after your injection
What is SYNVISC®/
SYNVISC® and Synvisc-One® (hylan G-F 20) are gel-like fluids used to treat pain associated with OA. They are viscosupplements that are biologically similar to hyaluronan. Hyaluronan is a component of synovial fluid that is responsible for its viscoelasticity. Synovial fluid lubricates the joint and acts as a shock absorber.
SYNVISC® is used in the knee, hip, ankle and shoulder while Synvisc-One® is used in the knee joint.
SYNVISC® provides pain relief that can last up to 26 weeks. Prospective clinical data in knee OA patients have shown benefit of treatment up to 52 weeks.*
Prospective clinical data in patients with OA of the knee have shown benefit of treatment up to 26 weeks following a single Synvisc-One® injection.*
SYNVISC® has been used to treat OA pain for over 30 years in Canada with 20+ million knees treated worldwide.
Ready to try SYNVISC® or Synvisc-One®?
Stock photo – posed by models.
* Each person responds differently to treatment and will experience different relief. It is important to speak with your healthcare provider about treatment expectations.